2-acetyl-4(5)-tetrahydroxybutylimidazole has been researched along with Contact Dermatitis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gugasyan, R; Losinno, C; Mandel, T | 1 |
| Boehm-Wilcox, C; Bosnic, M; Cope, RB; Reeve, VE | 1 |
2 other study(ies) available for 2-acetyl-4(5)-tetrahydroxybutylimidazole and Contact Dermatitis
| Article | Year |
|---|---|
The effect of 2-acetyl-4-tetrahydroxybutylimidazole on lymphocyte subsets during a contact hypersensitivity response in the NOD mouse.
Topics: Animals; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Cell Count; Dermatitis, Contact; Female; Imidazoles; Immunosuppressive Agents; Lymph Nodes; Lymphopenia; Mice; Mice, Inbred NOD; T-Lymphocyte Subsets | 1995 |
Pyridoxine supplementation protects mice from suppression of contact hypersensitivity induced by 2-acetyl-4-tetrahydroxybutylimidazole (THI), ultraviolet B radiation (280-320 nm), or cis-urocanic acid.
Topics: Animals; Dermatitis, Contact; Diet; Imidazoles; Immunosuppressive Agents; Mice; Pyridoxine; Ultraviolet Rays; Urocanic Acid | 1995 |